Madrona Venture Group, LLC

In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 11, 2025), Madrona Venture Group, LLC reported 3 stock positions worth $12.6 million. Its top holding was Uipath Class A (PATH) at 61.6% of the portfolio, followed by Nautilus Biotechnology (NAUT, 34.6%) and Ginkgo Bioworks (DNA, 3.8%). Compared with Q1 2025, it opened 1 new position and sold out of 1. The biggest buy was a new position in Ginkgo Bioworks (DNA) and the biggest sale an exit from Snowflake (SNOW).

Most Recent 13F
Q4 2025
Location
SEATTLE, WA
CIK
0001887785
Portfolio Value
$12.6M (Q2 2025)
SEC Filing
0001887785-25-000004 ↗ filed Aug 11, 2025

Holdings Value

0$50.0M$100.0M$150.0M Q1 2024: $117.5M Q1 2024 Q2 2024: $93.7M Q2 2024 Q3 2024: $74.6M Q3 2024 Q4 2024: $53.8M Q4 2024 Q1 2025: $28.5M Q1 2025 Q2 2025: $12.6M $12.6M Q2 2025 Q3 2025: $13.8M Q3 2025 Q4 2025: $22.1M Q4 2025

Holdings 3 stocks · $12.6M

PATH Uipath Inc. Class A 61.64% 607,673 $7.8M No change
NAUT Nautilus Biotechnology Inc. 34.58% 6,020,770 $4.4M No change
DNA Ginkgo Bioworks Holdings Inc. 3.78% 42,430 $477K New

Portfolio Sells Q1 2025 → Q2 2025

SNOW Snowflake Inc. Sold out 0.00% −59.83

Portfolio Buys Q1 2025 → Q2 2025

DNA Ginkgo Bioworks Holdings Inc. New 3.78% +3.78

All Filings

QuarterPositions13F Reported ValueTop Holdings
Q4 2025 3$22.1MNAUT, PATH, DNA
Q3 2025 3$13.8MPATH, NAUT, DNA
Q2 2025 3$12.6MPATH, NAUT, DNA
Q1 2025 3$28.5MSNOW, PATH, NAUT
Q4 2024 4$53.8MSNOW, NAUT, PATH, BCOV
Q3 2024 4$74.6MSNOW, NAUT, PATH, BCOV
Q2 2024 4$93.7MSNOW, NAUT, PATH, BCOV
Q1 2024 4$117.5MSNOW, NAUT, PATH, BCOV